This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on NA Companies: Veradermics, Incorporated (MANE) and Fiserv (FISV)

Tipranks - Tipranks - Wed Jun 17, 7:25AM CDT

Companies in the NA sector have received a lot of coverage today as analysts weigh in on Veradermics, Incorporated (MANE) and Fiserv (FISV).

Claim 55% Off TipRanks

Veradermics, Incorporated (MANE)

Veradermics, Incorporated received a Buy rating and a $135.00 price target from LifeSci Capital analyst Rami Katkhuda today. The company’s shares closed last Monday at $96.27.

According to TipRanks.com, Katkhuda is a 5-star analyst with an average return of 27.8% and a 52.7% success rate. Katkhuda covers the Healthcare sector, focusing on stocks such as Mineralys Therapeutics, Inc., MoonLake Immunotherapeutics, and Amylyx Pharmaceuticals Inc. ;'>

Currently, the analyst consensus on Veradermics, Incorporated is a Strong Buy with an average price target of $136.00, a 40.6% upside from current levels. In a report issued on June 2, Needham also initiated coverage with a Buy rating on the stock with a $136.00 price target.

See today’s best-performing stocks on TipRanks >>

Fiserv (FISV)

In a report released today, Matthew Coad from Truist Financial maintained a Hold rating on Fiserv. The company’s shares closed last Monday at $47.91.

According to TipRanks.com, Coad has 0 stars on 0-5 stars ranking scale with an average return of -5.8% and a 38.1% success rate. Coad covers the Technology sector, focusing on stocks such as Fidelity National Info, Bill.com Holdings, and Shift4 Payments. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Fiserv with a $68.81 average price target, a 39.5% upside from current levels. In a report released yesterday, TipRanks – PerPlexity also downgraded the stock to Hold with a $58.00 price target.

Read More on MANE:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).